Orthofix Medical Inc (OQ:OFIX)

Business Focus: Medical Equipment, Supplies & Distribution

May 20, 2024 09:00 pm ET
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
May 19, 2024 11:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
May 18, 2024 11:00 am ET
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
May 17, 2024 01:30 pm ET
IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
May 16, 2024 12:45 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
May 16, 2024 07:00 am ET
Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected as winner of the “Best Patient Experience Solution” award in the 8th annual MedTech Breakthrough Awards program.
May 15, 2024 03:30 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
May 09, 2024 07:00 am ET
Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Rodeo™ Telescopic Nail.
May 07, 2024 08:00 am ET
Orthofix Reports First Quarter 2024 Results
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the first quarter ended March 31, 2024.
Apr 30, 2024 09:10 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Apr 19, 2024 07:30 am ET
Lost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Apr 18, 2024 07:25 am ET
Orthofix Medical Inc. (OFIX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Apr 16, 2024 07:00 am ET
Orthofix Names Andres Cedron as New Chief Legal Officer
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer.
Apr 12, 2024 07:30 am ET
ATTENTION Orthofix Medical Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / April 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Apr 11, 2024 07:20 am ET
Levi & Korsinsky Reminds Orthofix Investors of the Ongoing Investigation into Potential Violations of Securities Laws - OFIX
NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Apr 10, 2024 07:25 am ET
Orthofix Medical Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- OFIX
NEW YORK, NY / ACCESSWIRE / April 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Apr 09, 2024 07:30 am ET
Shareholders that lost money on Orthofix Medical Inc.(OFIX) should contact Levi & Korsinsky about Securities Fraud Investigation - OFIX
NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Apr 08, 2024 07:20 am ET
Shareholders that lost money on Orthofix Medical Inc. (OFIX) should contact Levi & Korsinsky about Securities Fraud Investigation - OFIX
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 29, 2024 07:25 am ET
Lost Money on Orthofix Medical Inc.(OFIX)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 28, 2024 07:30 am ET
ATTENTION OFIX SHAREHOLDERS: Investors who lost money on Orthofix Medical Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESSWIRE / March 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 26, 2024 07:20 am ET
ATTENTION Orthofix Medical Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / March 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 25, 2024 07:30 am ET
OFIX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Orthofix Medical Inc. investment
NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 22, 2024 07:20 am ET
Levi & Korsinsky Reminds Shareholders of an Investigation into Orthofix Medical Inc. (OFIX) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / March 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 21, 2024 07:25 am ET
OFIX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Orthofix Medical Inc. investment
NEW YORK, NY / ACCESSWIRE / March 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 20, 2024 07:30 am ET
OFIX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Orthofix Medical Inc. Investment
NEW YORK, NY / ACCESSWIRE / March 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 19, 2024 07:20 am ET
OFIX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Orthofix Medical Inc. Shareholders Who Lost Money
NEW YORK, NY / ACCESSWIRE / March 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 18, 2024 07:00 am ET
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer.
Mar 14, 2024 04:30 pm ET
An Investigation Has Commenced on Behalf of Orthofix Medical Inc. Shareholders. Contact Levi & Korsinsky to Discuss your OFIX Losses.
NEW YORK, NY / ACCESSWIRE / March 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 13, 2024 07:25 am ET
Orthofix Medical Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - OFIX
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 12, 2024 07:30 am ET
ATTENTION Orthofix Medical Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 11, 2024 07:25 am ET
Shareholder Rights Advocates at Levi & Korsinsky Investigate Orthofix Medical Inc. (OFIX) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 08, 2024 07:30 am ET
Levi & Korsinsky Reminds Orthofix Investors of the Ongoing Investigation into Potential Violations of Securities Laws - OFIX
NEW YORK, NY / ACCESSWIRE / March 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 07, 2024 07:30 am ET
Orthofix Medical Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - OFIX
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 06, 2024 07:25 am ET
OFIX ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Orthofix Medical Inc.
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 05, 2024 04:03 pm ET
Orthofix Reports Fourth Quarter and Full Year 2023 Results
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the fourth quarter and year ended December 31, 2023, and issued guidance for the full year 2024.
Mar 05, 2024 07:30 am ET
Lost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Mar 04, 2024 07:25 am ET
Orthofix Being Investigated on Behalf of Orthofix Medical Inc. Investors. Contact Levi & Korsinsky For Details.
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Feb 29, 2024 07:00 am ET
Orthofix Announces New President for Bone Growth Therapies Business
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Jason Shallenberger to President of the Bone Growth Therapies business, and the realignment of its Spine business unit, effective March 1. A seasoned sales leader, Shallenberger previously served as Vice President of U.S. Sales and
Feb 27, 2024 12:30 pm ET
ATTENTION OFIX SHAREHOLDERS: Investors Who Lost Money on Orthofix Medical Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / February 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ:OFIX) concerning possible violations of federal securities laws.
Feb 21, 2024 07:00 am ET
Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.
Jan 18, 2024 07:00 am ET
Orthofix Announces Commercial Partnership with MRIguidance
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced it has entered into an agreement with
Jan 17, 2024 05:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Jan 16, 2024 07:00 am ET
Julie Andrews Begins as New Chief Financial Officer at Orthofix
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Julie Andrews has officially stepped into the role of Chief Financial Officer (CFO). A seasoned executive, Ms. Andrews previously served as CFO for Smart Wires Technology, a global transmission grid technology company focused on enabling the tra
Jan 16, 2024 05:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Jan 12, 2024 05:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Jan 09, 2024 08:00 am ET
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced preliminary unaudited fourth quarter 2023 net sales of approximately $200.3 million, an increase of 63.8% on a reported basis and 62.8% on a constant currency basis versus fourth quarter 2022. For the full year 2023, preliminary unaudited net sales were approximately $746.5 million, an increase of 62.0% on a reported basis and 61.5% on a constant currency basis.
Jan 08, 2024 11:45 pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Jan 08, 2024 07:00 am ET
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors. In conjunction with Mr. Calafiore stepping into his role as CEO, the Company has an
Dec 21, 2023 11:50 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Dec 21, 2023 07:00 am ET
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of new data from a prospective, multicenter study investigating Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct therapy to lumbar spinal fusion procedures in patients at risk for pseudarthrosis. Published in the
Dec 18, 2023 05:30 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Dec 14, 2023 04:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Dec 12, 2023 07:00 am ET
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. (NASDAQ: OFIX) (“Orthofix” or the “Company”) today announced the appointment of three new independent directors to the Company’s Board. These new directors bring substantial finance, strategic development, healthcare and medical technology experience to further advance Orthofix’s position as a leading global spine and orthopedics company. The appointments follow constructive engagement and entry into a cooperation agreement with Engine Capital Management, LP (together with its affiliates, “Engine”), one of the Company’s largest shareholders, which owns approximatel
Dec 11, 2023 01:04 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Orthofix Medical Inc. of an Investigation and Potential Class Action Lawsuit – (NASDAQ: OFIX)
The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc.: Due to the forgoing, The Gross Law Firm is investigating potential securities fraud claims on behalf of certain Orthofix investors. If you incurred a loss on...
Dec 10, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation...
Dec 01, 2023 05:16 pm ET
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, Dec. 1, 2023 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all compa
Nov 30, 2023 01:12 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Orthofix Medical Inc. of an Investigation and Potential Class Action Lawsuit – (NASDAQ: OFIX)
The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc.: Due to the forgoing, The Gross Law Firm is investigating potential securities fraud claims on behalf of certain Orthofix investors. If you incurred a loss on...
Nov 29, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation...
Nov 29, 2023 01:22 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Orthofix Medical Inc. (OFIX)
Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ: OFIX) concerning possible violations of federal securities laws. On September 12, 2023, Orthofix announced the “the...
Nov 29, 2023 12:21 pm ET
Lowey Dannenberg, P.C. is Investigating Orthofix Medical Inc. (NASDAQ: OFIX) for Potential Breaches of Fiduciary Duty by Its Board of Directors
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Orthofix Medical Inc. (“Orthofix” or the “Company”)...
Nov 29, 2023 07:00 am ET
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the
Nov 28, 2023 07:00 am ET
Orthofix Names Massimo Calafiore as President and Chief Executive Officer
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effectiv
Nov 27, 2023 01:17 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Orthofix Medical Inc. of an Investigation and Potential Class Action Lawsuit – (NASDAQ: OFIX)
The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc.: Due to the forgoing, The Gross Law Firm is investigating potential securities fraud claims on behalf of certain Orthofix investors. If you incurred a loss on...
Nov 27, 2023 10:48 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to Termination of Senior Ma
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Nov 25, 2023 08:30 am ET
ORTHOFIX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Nov 24, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation...
Nov 21, 2023 06:30 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to Termination of Senior Ma
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Nov 21, 2023 01:11 pm ET
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Orthofix Medical Inc. (OFIX) for Potential Violations of Securities Laws
Attention Orthofix Medical Inc. ("Orthofix") (NASDAQ: OFIX) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Orthofix and certain of its officers and directors regarding potential securities fraud....
Nov 20, 2023 01:06 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Orthofix Medical Inc. (OFIX)
Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical Inc. ("Orthofix ") (NASDAQ: OFIX) concerning possible violations of federal securities laws. On September 12, 2023, Orthofix announced the “the...
Nov 13, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation...
Nov 13, 2023 03:12 pm ET
OFIX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities L
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Nov 13, 2023 08:00 am ET
ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Nov 09, 2023 05:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 9, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Nov 08, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation...
Nov 08, 2023 04:07 pm ET
Orthofix Reports Third Quarter 2023 Results
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per share (“EPS”) was $(0.77), and adjusted EPS was $0.07.
Nov 08, 2023 08:00 am ET
ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Nov 07, 2023 03:59 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to Termination of Senior Ma
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Nov 07, 2023 01:00 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Nov 06, 2023 07:00 am ET
Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch of the WaveForm® L Lateral Lumbar Interbody System. Designed for lateral lumbar interbody fusion (LLIF) procedures, the 3D-printed WaveForm L features a porous structure that prioritizes strength and stabili
Nov 05, 2023 01:15 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 04, 2023 09:00 am ET
ORTHOFIX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Op
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national securities...
Nov 03, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation...
Nov 03, 2023 06:43 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Nov 03, 2023 09:00 am ET
ORTHOFIX SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Nov 02, 2023 04:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 31, 2023 01:48 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Oct 29, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, Dollar, and Clorox and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX), Dollar General Corporation (NYSE: DG), and The Clorox Company (NYSE: CLX). Our...
Oct 29, 2023 09:00 am ET
ORTHOFIX ONGOING INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Oct 27, 2023 03:53 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Oct 27, 2023 12:01 pm ET
OFIX ALERT: Hagens Berman, National Trial Attorneys, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to Termination
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Oct 25, 2023 09:01 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Oct 24, 2023 09:00 am ET
ORTHOFIX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Oct 23, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Viasat, Veradigm, and Orthofix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Viasat, Inc. (NASDAQ: VSAT), Veradigm, Inc. (NASDAQ: MDRX), and Orthofix Medical Inc. (NASDAQ: OFIX). Our investigations...
Oct 23, 2023 03:54 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Oct 19, 2023 04:38 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 19, 2023 09:00 am ET
ORTHOFIX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Oct 19, 2023 05:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 18, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX), and SCYNEXIS, Inc. (NASDAQ: SCYX). Our investigations concern whether these companies...
Oct 18, 2023 07:00 am ET
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.
Oct 17, 2023 09:48 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 16, 2023 11:26 am ET
OFIX SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Oct 16, 2023 04:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 16, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 13, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX), and Dollar General Corporation (NYSE: DG). Our investigations concern whether these...
Oct 13, 2023 08:40 pm ET
Orthofix Medical Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Orthofix Medical Inc. (NASDAQ: OFIX) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Orthofix stock. Orthofix investors are encouraged to contact the firm to...
Oct 12, 2023 09:10 am ET
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc.
NEW YORK, Oct. 12, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf  Haldenstein"), a preeminent national shareholder rights litigation firm, announces that is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX).
Oct 12, 2023 07:00 am ET
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove™, an advanced bioactive synthetic graft. Available in both a
Oct 11, 2023 03:56 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 11, 2023 10:00 am ET
ORTHOFIX ONGOING INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Oct 10, 2023 04:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 10, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 09, 2023 06:39 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 09, 2023 05:25 pm ET
Orthofix Medical Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Orthofix Medical Inc. (NASDAQ: OFIX) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Orthofix stock. Orthofix investors are encouraged to contact the firm to...
Oct 09, 2023 01:48 pm ET
Hagens Berman Encourages Orthofix Medical (OFIX) Shareholders to Contact the Firm
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Oct 08, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX), and Dollar General Corporation (NYSE: DG). Our investigations concern whether these...
Oct 07, 2023 07:15 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 06, 2023 05:19 pm ET
OFIX EQUITY ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation – OFIX
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Orthofix Medical Inc. (NASDAQ: OFIX) resulting from allegations that Orthofix may have issued...
Oct 06, 2023 10:00 am ET
ORTHOFIX ONGOING INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OFIX.
Oct 06, 2023 09:13 am ET
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc.
NEW YORK, Oct. 6, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX).
Oct 06, 2023 03:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES / ACCESSWIRE October 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 05, 2023 04:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 04, 2023 04:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 4, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 03, 2023 03:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Oct 03, 2023 02:49 pm ET
OFIX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Events Leading to Ter
Hagens Berman urges Orthofix Medical Inc. (NASDAQ: OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys. Visit:...
Oct 03, 2023 04:15 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Oct 02, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (NASDAQ: OFIX), and SCYNEXIS, Inc. (NASDAQ: SCYX). Our investigations concern whether these companies...
Sep 29, 2023 10:08 pm ET
OFIX LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation – OFIX
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Orthofix Medical Inc.  (NASDAQ: OFIX) resulting from allegations that Orthofix may have issued materially...
Sep 29, 2023 05:50 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Sep 29, 2023 03:30 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 28, 2023 04:00 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 27, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating FMC, and Orthofix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE: FMC), and Orthofix Medical Inc. (NASDAQ: OFIX). Our investigations concern whether these companies...
Sep 27, 2023 01:15 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 26, 2023 10:00 am ET
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation – OFIX
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Orthofix Medical Inc. (NASDAQ: OFIX) resulting from allegations that Orthofix may have issued materially misleading business information to the investing public.
Sep 25, 2023 07:12 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Sep 25, 2023 12:00 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 24, 2023 03:30 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ: OFIX) for violations of the securities laws.
Sep 22, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Lovesac, and Orthofix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Lovesac Company (NASDAQ: LOVE), and Orthofix Medical Inc. (NASDAQ: OFIX). Our investigations concern whether these companies...
Sep 22, 2023 02:00 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 21, 2023 06:04 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Sep 21, 2023 02:15 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 20, 2023 07:00 am ET
Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch and successful completion of the first cases with the
Sep 19, 2023 11:00 am ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ:
Sep 19, 2023 08:45 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses In Excess of $500,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 18, 2023 11:00 am ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
LOS ANGELES, Sept. 18, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX) investors concerning the Company's possible violations of the federal securities laws.  
Sep 18, 2023 07:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 17, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Veradigm, Holley, and Orthofix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Veradigm, Inc. (NASDAQ: MDRX), Holley Inc. (NYSE: HLLY), and Orthofix Medical Inc. (NASDAQ: OFIX). Our investigations...
Sep 17, 2023 07:10 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ: OFIX) for violations of the securities laws.
Sep 15, 2023 02:21 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
Law Offices of Howard G. Smith continues its investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) investors concerning the Company’s possible violations of federal securities laws.
Sep 15, 2023 06:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 14, 2023 09:00 pm ET
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of Orthofix stockholders. Our investigation concerns whether Orthofix has violated the federal securities laws and/or engaged in other unlawful business practices.
Sep 14, 2023 05:53 pm ET
The Law Offices of Frank R. Cruz Continues Its Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
The Law Offices of Frank R. Cruz continues its investigation of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ:
Sep 14, 2023 11:00 am ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ:
Sep 14, 2023 06:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses In Excess of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 13, 2023 04:59 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) investors concerning the Company’s possible violations of federal securities laws.
Sep 13, 2023 03:37 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Sep 13, 2023 06:00 am ET
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 13, 2023 04:08 am ET
Ademi LLP Investigates Claims of Securities Fraud against Orthofix Medical Inc.
MILWAUKEE, Sept. 13, 2023 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Orthofix (NASDAQ: OFIX). The investigation results from inaccurate statements Orthofix may have made regarding its business operations and prospects.
Sep 12, 2023 08:02 pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Orthofix Medical Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX) for violations of the securities laws.
Sep 12, 2023 07:31 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ:
Sep 12, 2023 12:05 pm ET
Investigation of Orthofix Medical Inc. (OFIX) Announced by Holzer & Holzer, LLC
Holzer & Holzer, LLC is investigating whether Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) complied with federal securities laws. On September 12, 2023, Orthofix announced it had terminated three executives in the Company for...
Sep 12, 2023 07:03 am ET
Orthofix Announces Leadership Changes
Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Board of Directors, has been appointed Interim Chief Executive Officer; Geoffrey Gillespie, Orthofix Vice President, Corporate Controller, has been appointed Interim Chief Financial Officer; and Puja Leekha, Orthofix Senior Vice President, Chief Ethics and Compliance Officer, has been appointed Interim Chief Legal Officer. The appointments are effective immediately and follow the unanimous decision by the Board’s independent directors to terminate f
Aug 31, 2023 08:00 am ET
Orthofix to Participate in Morgan Stanley Healthcare Conference
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in the Morgan Stanley Healthcare Conference in New York City. Management is scheduled to present on Tuesday, September 13, 2023 at 1:35 p.m. ET.
Aug 28, 2023 07:00 am ET
Orthofix Announces First Cases and Full Commercial Launch of the 7D FLASH Navigation System Percutaneous Module 2.0 for Minimally Invasive Surgery
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch and successful completion of the first cases in the U.S. with the 7D FLASH™ Navigation System Percutaneous Module 2.0. The Percutaneous Module 2.0 provides new planning features and increased functionality for t
Aug 23, 2023 07:00 am ET
Orthofix Medical to Host Investor Day on September 20, 2023
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the company will host an Investor Day at the Lewisville, TX headquarters on Wednesday, September 20, 2023 at 1:00pm Central Time.
Aug 08, 2023 04:08 pm ET
Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended June 30, 2023. Net sales were $187.0 million, earnings per share (“EPS”) was $(1.07), and adjusted EPS was $0.02.
Jul 25, 2023 07:00 am ET
Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 8, 2023, and Announces Participation in Upcoming Investor Conference
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its second quarter 2023 financial results on Tuesday, August 8, 2023 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.
Jun 28, 2023 07:00 am ET
Orthofix Introduces New Phantom and Tornado Hinges for TrueLok Ring Fixation Systems
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the launch of the TrueLok™ Phantom and Tornado Hinges, the latest addition to the Orthopedics TrueLok circular frame portfolio. Both hinges are designed for use with TrueLok circular frame offerings, including the
Jun 20, 2023 04:01 pm ET
Orthofix Announces Changes to Board of Directors
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik has been re-appointed as the Chair of the Company’s Board of Directors. Additionally, shareholders re-elected Wayne Burris who previously served on the Orthofix board from 2021-2022. Burris will serve on the Audit and Finance a
Jun 19, 2023 07:00 am ET
Orthofix Announces the Full Commercial Launch of WaveForm A 3D Printed Anterior Lumbar Interbody
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of the
Jun 01, 2023 07:00 am ET
Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the presentation of multiple clinical and scientific abstracts during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in San Francisco June 1-3, 2023.
May 09, 2023 04:01 pm ET
Orthofix Reports First Quarter 2023 Results
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended March 31, 2023. Net sales were $175.2 million, earnings per share (“EPS”) was $(1.71), and adjusted EPS was $(0.10).
May 04, 2023 07:00 am ET
MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the STIM onTrack™ mobile app was recognized as the “Best Patient Engagement Mobile App” by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the g
Apr 26, 2023 04:01 pm ET
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2023 financial results on Tuesday, May 9, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.
Apr 25, 2023 07:00 am ET
Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures. The
Mar 07, 2023 07:00 am ET
Orthofix Announces More Than 5,000 Fitbone Intramedullary Limb-lengthening Devices Implanted Worldwide to Date and Over Twenty Years of Clinical History
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced
Mar 06, 2023 04:01 pm ET
Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results
(NASDAQ:OFIX) The merger of Orthofix Medical Inc. ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023. This news release includes the financial results of stand-alone Orthofix and stand-alone SeaSpine for the fourth quarter and full year ended December 31, 2022. As such, these financial results do not include any potential accounting adjustments the merger may have on future net sales or operating results.
Mar 03, 2023 07:00 am ET
Orthofix Medical to Hold Analyst Teach-In Meeting on March 13, 2023
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will host an Analyst Teach-In Meeting in Lewisville, TX on Monday, March 13, 2023 from 2:30 - approximately 6:30 p.m. CT.
Feb 22, 2023 04:05 pm ET
Orthofix Medical to Present at Canaccord Genuity 2023 Musculoskeletal Conference
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will present at the upcoming Canaccord Genuity 2023 Musculoskeletal Conference in Las Vegas, NV. Management is scheduled to present on Tuesday, March 7, 2023, at 2:00 p.m. PT.
Feb 21, 2023 04:05 pm ET
Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter 2022 financial results of stand-alone Orthofix as well as stand-alone SeaSpine, which was merged into Orthofix effective January 5, 2023, on Monday, March 6, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.
Jan 26, 2023 07:00 am ET
Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of, and first patient cases involving, the Mariner® Deformity Pedicle Screw System.
Jan 09, 2023 07:00 am ET
Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
(NASDAQ:OFIX) The merger of equals between Orthofix Medical Inc. ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023. This news release includes the pre-merger unaudited preliminary net sales results of stand-alone SeaSpine and stand-alone Orthofix for the fourth quarter and full year ended December 31, 2022. As such, these preliminary financial results do not include any potential accounting adjustments that the merger may have on future net sales results.
Jan 04, 2023 04:01 pm ET
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each
Dec 22, 2022 07:00 am ET
Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced results from a prospective, multicenter clinical study evaluating the safety and efficacy of the Trinity Elite™ cellular bone allograft (CBA) in lumbar spinal fusion procedures. Published in
Dec 15, 2022 07:08 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFS, LBAI, OFIX, IMRA
NEW YORK, Dec. 15, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Dec 11, 2022 11:30 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMX, OFIX, MYOV, PEBO
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Maverix Metals Inc. (NYSE: MMX)’s...
Nov 18, 2022 07:27 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LFG, OFIX, KNBE, IMRA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Archaea Energy Inc. (NYSE: LFG)’s sale...
Nov 18, 2022 07:00 am ET
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company, effective upon the completion of their pending merger.
Nov 18, 2022 07:00 am ET
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that...
Nov 17, 2022 04:46 pm ET
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - OFIX, LMST, PFHD, RCOR
NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
Nov 17, 2022 09:16 am ET
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Orthofix Medical Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Orthofix Medical Inc. (NASDAQ: OFIX).
Nov 15, 2022 04:28 pm ET
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AIMC, OFIX, PEBO, FCRD
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Nov 15, 2022 09:55 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OFIX, KNBE, IMRA, LFG
NEW YORK, Nov. 15, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Nov 13, 2022 02:02 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ISR, SLDB, POSH, OFIX
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Isoray, Inc. (NYSE: ISR)’s merger with...
Nov 10, 2022 09:35 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OFIX, AAWW, AVEO, MYOV
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Nov 10, 2022 07:00 am ET
Orthofix Medical Announces Participation in Upcoming Stifel Healthcare Conference
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in a fireside chat during the upcoming Stifel 2022 Healthcare investor conference on Wednesday, November 16, 2022 at 8:00 a.m. ET. The conference will be held live at the Lotte New York Palace in NYC and one-on-one meetings will be held immediately following the fireside chat.
Nov 06, 2022 01:09 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OFIX, FORG, LFG, IMRA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Orthofix Medical Inc. (NASDAQ: OFIX)’s...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.